Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Harteneck

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 22, 2005
Function and pharmacology of TRPM cation channelsChristian Harteneck
Molecules (Basel, Switzerland)|October 3, 2013
Pregnenolone sulfate: from steroid metabolite to TRP channel ligandChristian Harteneck
Cell Calcium|May 27, 2003
Proteins modulating TRP channel functionChristian Harteneck
Current Pharmaceutical Biotechnology|October 12, 2010
Pharmacological modulation of diacylglycerol-sensitive TRPC3/6/7 channelsChristian Harteneck, Maik Gollasch
Reviews of Physiology, Biochemistry and Pharmacology|September 20, 2015
Hyperforin: To Be or Not to Be an Activator of TRPC(6)Kristina Friedland, Christian Harteneck
Pflugers Archiv : European Journal of Physiology|May 17, 2005
The mammalian melastatin-related transient receptor potential cation channels: an overviewRobert Kraft, Christian Harteneck
Cardiovascular Drug Reviews|April 21, 2007
N-(p-amylcinnamoyl)anthranilic acid (ACA): a phospholipase A(2) inhibitor and TRP channel blockerChristian Harteneck, Henning Frenzel, Robert Kraft
Advances in Experimental Medicine and Biology|February 4, 2011
Synthetic modulators of TRP channel activityChristian Harteneck, Chihab Klose, Dietmar Krautwurst
British Journal of Pharmacology|April 11, 2006
Inhibition of TRPM2 cation channels by N-(p-amylcinnamoyl)anthranilic acidRobert Kraft, Christian Grimm, Henning Frenzel, et al.
Molecular Pharmacology|November 20, 2004
Activation of the melastatin-related cation channel TRPM3 by D-erythro-sphingosine [corrected]Christian Grimm, Robert Kraft, Günter Schultz, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 22, 2005
Function and pharmacology of TRPM cation channelsChristian Harteneck
Molecules (Basel, Switzerland)|October 3, 2013
Pregnenolone sulfate: from steroid metabolite to TRP channel ligandChristian Harteneck
Cell Calcium|May 27, 2003
Proteins modulating TRP channel functionChristian Harteneck
Current Pharmaceutical Biotechnology|October 12, 2010
Pharmacological modulation of diacylglycerol-sensitive TRPC3/6/7 channelsChristian Harteneck, Maik Gollasch
Reviews of Physiology, Biochemistry and Pharmacology|September 20, 2015
Hyperforin: To Be or Not to Be an Activator of TRPC(6)Kristina Friedland, Christian Harteneck
Pflugers Archiv : European Journal of Physiology|May 17, 2005
The mammalian melastatin-related transient receptor potential cation channels: an overviewRobert Kraft, Christian Harteneck
Cardiovascular Drug Reviews|April 21, 2007
N-(p-amylcinnamoyl)anthranilic acid (ACA): a phospholipase A(2) inhibitor and TRP channel blockerChristian Harteneck, Henning Frenzel, Robert Kraft
Advances in Experimental Medicine and Biology|February 4, 2011
Synthetic modulators of TRP channel activityChristian Harteneck, Chihab Klose, Dietmar Krautwurst
British Journal of Pharmacology|April 11, 2006
Inhibition of TRPM2 cation channels by N-(p-amylcinnamoyl)anthranilic acidRobert Kraft, Christian Grimm, Henning Frenzel, et al.
Molecular Pharmacology|November 20, 2004
Activation of the melastatin-related cation channel TRPM3 by D-erythro-sphingosine [corrected]Christian Grimm, Robert Kraft, Günter Schultz, et al.
Pageof 5